{"id":"00ff3dd3b77b","type":"article","url":"https://hartvaat.nl/2016/01/26/p-selectine-antagonist-inclacumab-bij-coronaire-bypasschirurgie-select-cabg-tria/","title":"P-selectine-antagonist inclacumab bij coronaire bypasschirurgie: SELECT-CABG-trial","title_en":"Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG Trial.","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":["newton-cabg"],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2015.10.071","source_url":"https://doi.org/10.1016/j.jacc.2015.10.071","authors":["Barbara E Stähli","Jean-Claude Tardif","Michel Carrier","Richard Gallo","Robert W Emery","Stephen Robb","Daniel Cournoyer","Lucie Blondeau","Dominique Johnson","Jessica Mann","Jacques Lespérance","Marie-Claude Guertin","Philippe L L'Allier"],"significance":5,"published":"2016-01-26","source_date":"2016-01-26","image":"","kennis":["https://hartvaat.nl/kennis/coronairlijden/cabg-bypasschirurgie/","https://hartvaat.nl/kennis/vasculair/vaatchirurgie-perioperatief-cardiologisch-beleid/"],"congress":"","summary_en":"The SELECT-CABG trial tested inclacumab, a P-selectin antagonist, for reducing perioperative myocardial injury during CABG, exploring anti-adhesion molecule therapy for surgical cardioprotection.","created":"2026-07-03T10:25:54Z","updated":"2026-07-03T13:25:16Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Gerandomiseerde trial die het effect onderzocht van inclacumab, een P-selectine-antagonist, op myocardschade bij patiënten die CABG ondergingen. Onderzocht of remming van leukocyt-endotheelinteractie perioperatieve schade kan verminderen.","abstract_original":""}